These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 15525846)

  • 21. [Ocular complications of giant cell arteritis].
    Liozon E; Ly KH; Robert PY
    Rev Med Interne; 2013 Jul; 34(7):421-30. PubMed ID: 23523078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Features and prognosis of giant cell arteritis in patients over 85 years of age: A case-control study.
    Liozon E; Delmas C; Dumonteil S; Dumont A; Gondran G; Bezanahary H; Aouba A; Fauchais AL; Ly KH; de Boysson H
    Semin Arthritis Rheum; 2019 Oct; 49(2):288-295. PubMed ID: 30910217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ischaemic manifestations in giant cell arteritis are associated with area level socio-economic deprivation, but not cardiovascular risk factors.
    Mackie SL; Dasgupta B; Hordon L; Gough A; Green M; Hollywood J; Dutta S; Bejarano V; Jarrett S; Morgan AW; Pease CT;
    Rheumatology (Oxford); 2011 Nov; 50(11):2014-22. PubMed ID: 21859697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of antiplatelet therapy in the development of severe ischemic complications and in the outcome of patients with giant cell arteritis.
    Narváez J; Bernad B; Gómez-Vaquero C; García-Gómez C; Roig-Vilaseca D; Juanola X; Rodriguez-Moreno J; Nolla JM; Valverde J
    Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S57-62. PubMed ID: 18799055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study.
    Gonzalez-Gay MA; Miranda-Filloy JA; Lopez-Diaz MJ; Perez-Alvarez R; Gonzalez-Juanatey C; Sanchez-Andrade A; Martin J; Llorca J
    Medicine (Baltimore); 2007 Mar; 86(2):61-68. PubMed ID: 17435586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of Giant Cell Arteritis after Treating Polymyalgia or Peripheral Arthritis: A Retrospective Case-control Study.
    Liozon E; de Boysson H; Dalmay F; Gondran G; Bezanahary H; Fauchais AL; Ly KH
    J Rheumatol; 2018 May; 45(5):678-685. PubMed ID: 29545449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New-onset giant cell arteritis with lower ESR and CRP level carries a similar ischemic risk to other forms of the disease but has an excellent late prognosis: a case-control study.
    Liozon E; Parreau S; Dumonteil S; Gondran G; Bezanahary H; Ly KH; Fauchais AL
    Rheumatol Int; 2023 Jul; 43(7):1323-1331. PubMed ID: 37024620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of antiplatelet/anticoagulant therapy on severe ischemic complications in patients with giant cell arteritis: a cumulative meta-analysis.
    Martínez-Taboada VM; López-Hoyos M; Narvaez J; Muñoz-Cacho P
    Autoimmun Rev; 2014 Aug; 13(8):788-94. PubMed ID: 24667078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of visual manifestations and identification of risk factors for permanent vision loss in patients with giant cell arteritis.
    Baalbaki H; Jalaledin D; Lachance C; Febrer G; Rhéaume M; Makhzoum JP
    Clin Rheumatol; 2021 Aug; 40(8):3207-3217. PubMed ID: 33580374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statin therapy does not seem to benefit giant cell arteritis.
    Narváez J; Bernad B; Nolla JM; Valverde J
    Semin Arthritis Rheum; 2007 Apr; 36(5):322-7. PubMed ID: 17204308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Giant cell arteritis. A study of 191 patients].
    Armona J; Rodríguez-Valverde V; González-Gay MA; Figueroa M; Fernández-Sueiro JL; Blanco R; Martínez-Taboada V
    Med Clin (Barc); 1995 Dec; 105(19):734-7. PubMed ID: 8523954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiplatelet and anticoagulant therapy in patients with giant cell arteritis.
    Lee MS; Smith SD; Galor A; Hoffman GS
    Arthritis Rheum; 2006 Oct; 54(10):3306-9. PubMed ID: 17009265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study.
    Gonzalez-Gay MA; Garcia-Porrua C; Piñeiro A; Pego-Reigosa R; Llorca J; Hunder GG
    Medicine (Baltimore); 2004 Nov; 83(6):335-341. PubMed ID: 15525845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Giant cell arteritis update.
    Neff AG; Greifenstein EM
    Semin Ophthalmol; 1999 Jun; 14(2):109-12. PubMed ID: 10758218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Giant cell arteritis without clinically evident vascular involvement in a defined population.
    Gonzalez-Gay MA; Garcia-Porrua C; Amor-Dorado JC; Llorca J
    Arthritis Rheum; 2004 Apr; 51(2):274-7. PubMed ID: 15077272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohort.
    Singh AG; Kermani TA; Crowson CS; Weyand CM; Matteson EL; Warrington KJ
    J Rheumatol; 2015 Feb; 42(2):309-15. PubMed ID: 25512481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term follow-up of upper and lower extremity vasculitis related to giant cell arteritis: a series of 36 patients.
    Assie C; Janvresse A; Plissonnier D; Levesque H; Marie I
    Medicine (Baltimore); 2011 Jan; 90(1):40-51. PubMed ID: 21200185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Giant cell arteritis in Lugo, Spain: a more frequent disease with fewer classic features.
    González-Gay MA; Blanco R; Sánchez-Andrade A; Vázquez-Caruncho M
    J Rheumatol; 1997 Nov; 24(11):2166-70. PubMed ID: 9375879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for cranial ischemic complications in giant cell arteritis.
    Nesher G; Berkun Y; Mates M; Baras M; Nesher R; Rubinow A; Sonnenblick M
    Medicine (Baltimore); 2004 Mar; 83(2):114-122. PubMed ID: 15028965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition.
    Berger CT; Wolbers M; Meyer P; Daikeler T; Hess C
    Rheumatology (Oxford); 2009 Mar; 48(3):258-61. PubMed ID: 19129348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.